AAAAAA
Results:
1-11
|
Results: 11
Authors:
Suhy, J
Rooney, WD
Goodkin, DE
Capizzano, AA
Soher, BJ
Maudsley, AA
Waubant, E
Andersson, PB
Weiner, MW
Citation: J. Suhy et al., H-1 MRSI comparison of white matter and lesions in primary progressive andrelapsing-remitting MS, MULT SCLER, 6(3), 2000, pp. 148-155
Authors:
Tregoning, SK
Ballard, RC
Andersson, PB
Fehler, HG
van der Spuy, ZM
Citation: Sk. Tregoning et al., Antibodies to Chlamydia trachomatis in patients presenting with ectopic pregnancy at Groote Schuur Hospital, S AFR MED J, 90(7), 2000, pp. 727
Authors:
Goodkin, DE
Shulman, M
Winkelhake, MJ
Waubant, E
Andersson, PB
Stewart, T
Nelson, S
Fischbein, N
Coyle, PK
Frohman, E
Jacobs, L
Holcenberg, J
Lee, M
Mocci, S
Citation: De. Goodkin et al., A phase I trial of solubilized DR2 : MBp(84-102) (AG284) in multiple sclerosis, NEUROLOGY, 54(7), 2000, pp. 1414-1420
Authors:
Andersson, PB
Yuen, E
Parko, K
So, YT
Citation: Pb. Andersson et al., Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies, NEUROLOGY, 54(1), 2000, pp. 40-44
Authors:
Waubant, E
Sloan, R
Andersson, PB
Goodkin, D
Citation: E. Waubant et al., A pilot study of the effect of weekly intramuscular 30 mcg interferon beta-1a (Avonex (TM)) on monthly gadolinium-enhanced brain MRI activity in patients with relapsing multiple sclerosis., REV NEUROL, 155, 1999, pp. S20-S23
Authors:
Waubant, E
Goodkin, DE
Gee, L
Bacchetti, P
Sloan, R
Stewart, T
Andersson, PB
Stabler, G
Miller, K
Citation: E. Waubant et al., Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis, NEUROLOGY, 53(7), 1999, pp. 1397-1401
Authors:
Katz, JS
Wolfe, GI
Andersson, PB
Saperstein, DS
Elliott, JL
Nations, SP
Bryan, WW
Barohn, RJ
Citation: Js. Katz et al., Brachial amyotrophic diplegia - A slowly progressive motor neuron disorder, NEUROLOGY, 53(5), 1999, pp. 1071-1076
Authors:
Waubant, E
Goodkin, DE
Sloan, R
Andersson, PB
Citation: E. Waubant et al., A pilot study of MRI activity before and during interferon beta-1a therapy, NEUROLOGY, 53(4), 1999, pp. 874-876
Authors:
Andersson, PB
Waubant, E
Gee, L
Goodkin, DE
Citation: Pb. Andersson et al., Multiple sclerosis that is progressive from the time of onset - Clinical characteristics and progression of disability, ARCH NEUROL, 56(9), 1999, pp. 1138-1142
Authors:
Waubant, E
Sloan, R
Gee, L
Stewart, T
Andersson, PB
Stabler, G
Miller, K
Goodkin, D
Citation: E. Waubant et al., Serum level of matrix metalloprotease-9 (MMP-9) and natural tissue inhibitor of MMP type 1 (TIMP-1) in patients with relapsing-remitting multiple sclerosis (RRMS): Relationship to MRI activity, MULT SCLER, 4(6), 1998, pp. 507-507
Authors:
Goodkin, DE
Andersson, PB
Waubant, E
Stewart, T
Garia, A
Chan, A
Goldstein, R
Nelson, S
Coyle, P
Frohman, E
Jacobs, L
Lee, M
Winkelhake, J
Holcenberg, J
Shulman, M
Citation: De. Goodkin et al., A double blind, dose escalation study of safety and tolerability of IV AG284 in patients with SP multiple sclerosis, MULT SCLER, 4(6), 1998, pp. 508-508
Risultati:
1-11
|